Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Cadbury Schweppes

7 Mar 2005 07:00

Embargoed Release: 07:00 hrs Monday 7th March 2005 SOPHEON PLC (`Sopheon' or `the Company') Product Innovation Focus Prompts Cadbury Schweppes to Deploy Sopheon Portfolio and Process Management System Food and Beverage Leader Implements Accolade Enterprise-wide to Support Integrated Portfolio Management, Increase Revenue from New Products Sopheon, the international software and services company, announced today thatCadbury Schweppes, a leading global confectionary and beverage company, hasselected Sopheon's Accolade portfolio and process management system to enhancea company-wide integrated portfolio management initiative aimed at increasinggrowth from innovation. The Accolade deployment spans 45 countries and includes2,400 users in product development, marketing and commercial strategy. Itencompasses all five of Cadbury's operating regions, specifically AmericasBeverages; Americas Confectionery; Europe, Middle East and Africa; EuropeanBeverages; and Asia Pacific.One of the largest international confectionery and beverage companies in theworld, Cadbury Schweppes employs well over 50,000 people and has an impressivelist of popular brand name products, including Cadbury, Schweppes, Halls,Trident, Dr Pepper, Snapple, Trebor and Dentyne. Sopheon's Accolade will beused both to support product portfolio management and to automate and managethe company's implementation of Stage-Gate, a widely-used product developmentprocess methodology. The software system will serve as a central repository forproduct information within business units and across the company. Accolade waschosen because of its ease-of-use, speed and ease of deployment, comprehensiveportfolio decision-support capabilities and overall cost-effectiveness."Cadbury Schweppes' stature as a leading innovator reaches back over 200years," said Christine Connelly, chief information officer at CadburySchweppes. "We are determined that this commitment to innovation will be asmuch a part of our future as it has been our past. To maintain ourmarket-leading position, we have outlined an organic growth strategy thatrelies upon our ability to innovate well and achieve high levels of return onour innovation investments. Sopheon's Accolade will give us the processuniformity and performance consistency we need to enable the sharing ofknowledge and expertise across a common process and system platform, ensuringfaster time-to-market with winning products.""The list of `most admired' companies adopting Sopheon's Accolade systemcontinues to grow," said Mike Connolly, Sopheon's director of sales in the U.K."Cadbury Schweppes is an industry vanguard with a clear vision of what it takesto drive innovation across geographies, organizational and functionalboundaries, and product categories to sustain business success. The company'sdecision to deploy Accolade reflects and affirms our solution's capacity tohandle the critical and unique product-portfolio and process-management needsof food and beverage manufacturers. We are delighted by the opportunity topartner with Cadbury Schweppes in the pursuit of its innovation and businessgoals."Sopheon Accolade‚® is a registered trademark of Sopheon plc.All other trademarks and registered trademarks are the soleproperty of their respective owners.About Cadbury SchweppesCadbury Schweppes (LSE: CBRY) is a major global group which manufactures,markets and distributes branded confectionery and beverage products around theworld. With origins stretching back over 200 years, today Cadbury Schweppes'products-which include brands such as Cadbury, Schweppes, Halls, Trident, DrPepper, Snapple, Trebor, Dentyne, Bubblicious and Bassett-are enjoyed in almostevery country around the world. In 2004, Cadbury Schweppes was voted Britain'smost admired company by its peers. It is number one in sugar and functionalconfectionery, a strong number two in gum and the world's third-largest softdrinks group. For more information, please visit www.cadburyschweppes.com.About SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade‚® product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevantcontent to healthcare and engineering professionals to enable effectivecompliance with protocols, standards and regulations. Sopheon is listed on theAIM Market of the London Stock Exchange and on the Euronext in the Netherlands.For more information, please visit www.sopheon.com. # # # For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010END
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.